Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
78M
-
Shares change
-
-1.75M
-
Total reported value, excl. options
-
$235M
-
Value change
-
-$11.5M
-
Put/Call ratio
-
4.86
-
Number of buys
-
77
-
Number of sells
-
-39
-
Price
-
$3.01
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q1 2023
138 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q1 2023.
Erasca, Inc. - Common Stock (ERAS) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78M shares
of 283M outstanding shares and own 27.54% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (11.1M shares), Cormorant Asset Management, LP (10.8M shares), ARMISTICE CAPITAL, LLC (7.35M shares), VANGUARD GROUP INC (6.04M shares), BlackRock Inc. (5.37M shares), PFM Health Sciences, LP (4.8M shares), Artal Group S.A. (4.72M shares), CITADEL ADVISORS LLC (3.33M shares), BANK OF AMERICA CORP /DE/ (2.98M shares), and MILLENNIUM MANAGEMENT LLC (1.61M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.